A SIDE-CHAIN AT POSITION-48 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE FLAP PROVIDES AN ADDITIONAL SPECIFICITY DETERMINANT

被引:15
作者
MOODY, MD
PETTIT, SC
SHAO, W
EVERITT, L
LOEB, DD
HUTCHISON, CA
SWANSTROM, R
机构
[1] UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA
[3] UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA
关键词
D O I
10.1006/viro.1995.1107
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Substitution of glycine with glutamic acid at position 48 of the human immunodeficiency virus protease resulted in an enzyme with reduced activity on one of the protease processing sites in the viral Pol polyprotein precursor. Cleavage at this site was restored by a second-site substitution in the substrate replacing an aspartic acid with either glycine or asparagine. These results suggest that the glutamic acid side chain in the mutant protease has an unfavorable charge-charge interaction with this position in the substrate. Cleavage of a processing site in the viral Gag polyprotein precursor with the mutant enzyme was enhanced, and this enhancement was dependent on the presence of an arginine residue in the substrate, again suggesting a charge-charge interaction. The potential for such interactions was confirmed using molecular modeling. The effect of the position 48 substitution was attributed to a 10-fold increase in K-m for the processing site in Pol. These results indicate that the addition of a side chain at position 48 can alter the specificity of the HIV-1 protease to substrate in a sequence specific manner and that compensatory changes can be made in the substrate. (C) 1995 Academic Press, Inc.
引用
收藏
页码:475 / 485
页数:11
相关论文
共 45 条
  • [1] BEAUMONT A, 1992, J BIOL CHEM, V267, P2138
  • [2] THE USE OF NATIVE T7 DNA-POLYMERASE FOR SITE-DIRECTED MUTAGENESIS
    BEBENEK, K
    KUNKEL, TA
    [J]. NUCLEIC ACIDS RESEARCH, 1989, 17 (13) : 5408 - 5408
  • [3] CAMERON CE, 1994, J BIOL CHEM, V269, P11170
  • [4] HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS
    DARKE, PL
    NUTT, RF
    BRADY, SF
    GARSKY, VM
    CICCARONE, TM
    LEU, CT
    LUMMA, PK
    FREIDINGER, RM
    VEBER, DF
    SIGAL, IS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) : 297 - 303
  • [5] CRYSTAL-STRUCTURE OF THE RIBONUCLEASE-H DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE
    DAVIES, JF
    HOSTOMSKA, Z
    HOSTOMSKY, Z
    JORDAN, SR
    MATTHEWS, DA
    [J]. SCIENCE, 1991, 252 (5002) : 88 - 95
  • [6] GENERATION AND CHARACTERIZATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) MUTANT RESISTANT TO AN HIV-1 PROTEASE INHIBITOR
    ELFARRASH, MA
    KURODA, MJ
    KITAZAKI, T
    MASUDA, T
    KATO, K
    HATANAKA, M
    HARADA, S
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (01) : 233 - 239
  • [7] CLEAVAGE OF HIV-1 GAG POLYPROTEIN SYNTHESIZED INVITRO - SEQUENTIAL CLEAVAGE BY THE VIRAL PROTEASE
    ERICKSONVIITANEN, S
    MANFREDI, J
    VIITANEN, P
    TRIBE, DE
    TRITCH, R
    HUTCHISON, CA
    LOEB, DD
    SWANSTROM, R
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (06) : 577 - 591
  • [8] EXPRESSION AND PROCESSING OF THE AIDS VIRUS REVERSE-TRANSCRIPTASE IN ESCHERICHIA-COLI
    FARMERIE, WG
    LOEB, DD
    CASAVANT, NC
    HUTCHISON, CA
    EDGELL, MH
    SWANSTROM, R
    [J]. SCIENCE, 1987, 236 (4799) : 305 - 308
  • [9] PCR AMPLIFICATION OF HIV-1 PROTEINASE SEQUENCES DIRECTLY FROM LAB ISOLATES ALLOWS DETERMINATION OF 5 CONSERVED DOMAINS
    FONTENOT, G
    JOHNSTON, K
    COHEN, JC
    GALLAHER, WR
    ROBINSON, J
    LUFTIG, RB
    [J]. VIROLOGY, 1992, 190 (01) : 1 - 10
  • [10] PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF RECOMBINANT SIMIAN IMMUNODEFICIENCY VIRUS PROTEASE AND COMPARISON TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    GRANT, SK
    DECKMAN, IC
    MINNICH, MD
    CULP, J
    FRANKLIN, S
    DREYER, GB
    TOMASZEK, TA
    DEBOUCK, C
    MEEK, TD
    [J]. BIOCHEMISTRY, 1991, 30 (34) : 8424 - 8434